current hurdles in aav-based gene therapy for hemophilia
Published 1 year ago • 652 plays • Length 2:23Download video MP4
Download video MP3
Similar videos
-
1:57
aav gene therapies for hemophilia a and b
-
10:42
a detailed overview of the current and emerging gene therapies for hemophilia a & b
-
3:07
aav-based gene therapy in hemophilia a and b: valoctocogene roxaparvovec & etranacogene dezaparvovec
-
6:27
adeno-associated virus mediated gene transfer for hemophilia b
-
3:57
first-in-human gene therapy study of bay 2599023 in severe hemophilia a
-
20:34
gene therapy for treatment of hemophilia: aav vector gene therapy application to hemophilia
-
23:28
gene therapy for treatment of hemophilia: an introduction to aav vector gene transfer
-
1:12
promising novel agents for hemophilia a/b: gene therapies and extended half-life products
-
1:09
highlights from isth: gene therapy in hemophilia a & undiagnosed bleeding disorders in pediatrics
-
3:38
gene therapy: an end to hemophilia
-
1:06
overview of the diagnostic work-up for hemophilia
-
1:40
choosing between gene therapy and allosct for scd
-
4:15
synthetic aav vectors for gene therapy of hemophilia in children
-
1:17
the current standard of care in hemophilia and unmet needs in this space
-
1:09:16
preparing for practice readiness in gene therapy for hemophilia
-
2:03
the current landscape of treatment for bpdcn
-
0:45
difference between quality of life & patient-reported outcomes
-
1:42
bgtc: aav animation
-
2:38
the vital role of nursing in the diagnosis and management of acute & chronic gvhd